Literature DB >> 8884192

Low prevalence of diphtheria immunity in the population of Florence, Italy.

N Comodo1, P Bonanni, A Lo Nostro, E Tiscione, F Mannelli, A Tomei.   

Abstract

A seroepidemiological study was conducted in 1994 on a representative sample of the population of Florence in order to verify the immunity coverage against diphtheria. Subjects were divided according to sex and age class. Sera from each selected class were at least 1.5/1000 of the residing population. Diphtheria antitoxin was titrated using a quantitative ELISA test. The results show an overall adjusted prevalence of diphtheria immunity (> or = 0.01 IU/ml) equal to 63.7%. Subjects of younger age classes have good protection levels (85.5% immune under 30 years), while only half individuals aged > or = 50 years have antibody titres > or = 0.01 IU/ml. Full protection (antibody titre > or = 0.1 IU/ml) was detected only in a very small proportion of those aged > or = 40 years. Our data show (1) how a recrudescence of diphtheria could theoretically take place in older subjects living in Italy, and (2) stress the importance of periodical re-vaccination of adults.

Mesh:

Substances:

Year:  1996        PMID: 8884192     DOI: 10.1007/bf00145414

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

Review 1.  Vaccination against tetanus and diphtheria. Evaluations of immunity in the Danish population, guidelines for revaccination, and methods for control of vaccination programs.

Authors:  O Simonsen
Journal:  Dan Med Bull       Date:  1989-02

2.  Immunity to diphtheria in the 3-19 year age group in Italy.

Authors:  A Chiarini; A Giammanco; T Stroffolini; D De Mattia; M D Masia; A Sarzana; S Taormina; M Maggio; G Rigo; M Chiaramonte
Journal:  Vaccine       Date:  1991-11       Impact factor: 3.641

3.  Diphtheria outbreak--Russian Federation, 1990-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-11-05       Impact factor: 17.586

4.  Expanded programme on immunization.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1993-09-03

5.  Diphtheria after visit to Russia.

Authors:  J Lumio; M Jahkola; R Vuento; O Haikala; J Eskola
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

6.  Susceptibility to diphtheria.

Authors:  J V Dadswell
Journal:  Lancet       Date:  1978-02-25       Impact factor: 79.321

7.  The changing epidemiology of diphtheria in Jordan.

Authors:  N Khuri-Bulos; Y Hamzah; S M Sammerrai; A Shehabi; R Hamed; M A Arnaout; J Turk; H Qubain
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

8.  Immunity against diphtheria in adults in Poland.

Authors:  A Galazka; B Kardymowicz
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

9.  Diphtheria in the United States, 1971-81.

Authors:  R T Chen; C V Broome; R A Weinstein; R Weaver; T F Tsai
Journal:  Am J Public Health       Date:  1985-12       Impact factor: 9.308

10.  Childhood vaccination coverage in Italy: results of a seven-region survey. The Italian Vaccine Coverage Survey Working Group.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

View more
  4 in total

1.  Diphtheria antitoxin levels in the 14-30-year age group in Italy.

Authors:  I Mastroeni; A M Patti; A L Santi; N Vescia; S Bocchini; S Bagnod; C Ciapetti; G M Fara
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

2.  Diphtheria: epidemiological update and review of prevention and control strategies.

Authors:  E Prospero; M Raffo; M Bagnoli; R Appignanesi; M M D'Errico
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

3.  A multicentre serosurvey on diphtheria immunity in a French population of 1004 subjects.

Authors:  F Ballereau; I Schrive; A Fisch; M Speich; H Laurichesse; S Tournade; M Rey
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

4.  The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV).

Authors:  P Laroche; M Barrand; S C Wood; K Van Hasbrouck; J Lang; E Harzer; L Hessel
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 7.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.